Selected cardiovascular diseases in psoriasis, nonpsoriasis, and efalizumab-treated psoriasis patients

被引：0
|
作者：
Eng, Susan [1 ]
Xing, Biao [1 ]
Caro, Ivor [1 ]
Werther, Winifred [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2009年 / 60卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB182 / AB182
页数：1
相关论文
共 50 条
  • [21] The Association Between Psoriasis and Cardiovascular Diseases
    Kalkan, Goknur
    Karadag, A. Serap
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2013, 10 : 10 - 16
  • [22] Psoriasis as a risk factor of cardiovascular diseases
    Komorowska, Olivia Rita
    Szczerkowska-Dobosz, Aneta
    Purzycka-Bohdan, Dorota
    Rawicz-Zegrzda, Dorota
    Dudziak, Maria
    PRZEGLAD DERMATOLOGICZNY, 2014, 101 (06): : 500 - 506
  • [23] Efalizumab withdrawalPsoriatic arthritis in patients with psoriasis: 2 case reports
    Reactions Weekly, 2007, 1154 (1) : 12 - 12
  • [24] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    Wang, X
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
  • [25] The Heartbreak of Psoriasis A Review of Cardiovascular Risk in Patients With Psoriasis
    Benson, Max M.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2015, 23 (06) : 312 - 316
  • [26] The Problems that Occurred after Discontinuation of Efalizumab Therapy in Psoriasis Patients
    Adisen, Esra
    Tezel, Fulya
    Gurer, Mehmet Ali
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2010, 44 (01): : 19 - 24
  • [27] New onset, debilitating arthritis in psoriasis patients receiving efalizumab
    Myers, W. A.
    Najarian, D.
    Gottlieb, A. B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 108 - 108
  • [28] Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients
    Wakkee, M.
    Thio, H. B.
    Prens, E. P.
    Slibrands, E. J. G.
    Neumann, H. A. M.
    ATHEROSCLEROSIS, 2007, 190 (01) : 1 - 9
  • [29] Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment
    Kop, Else N.
    Korver, John E. M.
    Van Ruysevelt, Delphine
    De Jong, Elke M. G. J.
    Van der Valk, Pieter G.
    Van de Kerkhof, Peter C. M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2009, 20 (01) : 67 - 69
  • [30] Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
    Kothary, Namita
    Diak, Ida-Lina
    Brinker, Allen
    Bezabeh, Shewit
    Avigan, Mark
    Dal Pan, Gerald
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (03) : 546 - 551
12345